Literature DB >> 16854979

Defining the requirements for Hsp40 and Hsp70 in the Hsp90 chaperone pathway.

Nela S Cintron1, David Toft.   

Abstract

The Hsp90 chaperoning pathway and its model client substrate, the progesterone receptor (PR), have been used extensively to study chaperone complex formation and maturation of a client substrate in a near native state. This chaperoning pathway can be reconstituted in vitro with the addition of five proteins plus ATP: Hsp40, Hsp70, Hop, Hsp90, and p23. The addition of these proteins is necessary to reconstitute hormone-binding capacity to the immuno-isolated PR. It was recently shown that the first step for the recognition of PR by this system is binding by Hsp40. We compared type I and type II Hsp40 proteins and created point mutations in Hsp40 and Hsp70 to understand the requirements for this first step. The type I proteins, Ydj1 and DjA1 (HDJ2), and a type II, DjB1 (HDJ1), act similarly in promoting hormone binding and Hsp70 association to PR, while having different binding characteristics to PR. Ydj1 and DjA1 bind tightly to PR whereas the binding of DjB1 apparently has rapid on and off rates and its binding cannot be observed by antibody pull-down methods using either purified proteins or cell lysates. Mutation studies indicate that client binding, interactions between Hsp40 and Hsp70, plus ATP hydrolysis by Hsp70 are all required to promote conformational maturation of PR via the Hsp90 pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854979     DOI: 10.1074/jbc.M605417200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights.

Authors:  Mikko Taipale; Daniel F Jarosz; Susan Lindquist
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-09       Impact factor: 94.444

Review 2.  Mechanisms of the Hsp70 chaperone system.

Authors:  Jason C Young
Journal:  Biochem Cell Biol       Date:  2010-04       Impact factor: 3.626

3.  Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal.

Authors:  Siu Chiu Chan; Yingming Li; Scott M Dehm
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

Review 4.  Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.

Authors:  Amanda K Davis; William B Pratt; Andrew P Lieberman; Yoichi Osawa
Journal:  Cell Mol Life Sci       Date:  2019-09-24       Impact factor: 9.261

Review 5.  Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions.

Authors:  David F Smith; David O Toft
Journal:  Mol Endocrinol       Date:  2008-05-01

Review 6.  It's not magic - Hsp90 and its effects on genetic and epigenetic variation.

Authors:  Rebecca A Zabinsky; Grace Alexandria Mason; Christine Queitsch; Daniel F Jarosz
Journal:  Semin Cell Dev Biol       Date:  2018-06-06       Impact factor: 7.727

7.  Metazoan Hsp70 machines use Hsp110 to power protein disaggregation.

Authors:  Heike Rampelt; Janine Kirstein-Miles; Nadinath B Nillegoda; Kang Chi; Sebastian R Scholz; Richard I Morimoto; Bernd Bukau
Journal:  EMBO J       Date:  2012-09-18       Impact factor: 11.598

8.  The Yeast Hsp70 Cochaperone Ydj1 Regulates Functional Distinction of Ssa Hsp70s in the Hsp90 Chaperoning Pathway.

Authors:  Deepika Gaur; Prashant Singh; Jyoti Guleria; Arpit Gupta; Satinderdeep Kaur; Deepak Sharma
Journal:  Genetics       Date:  2020-04-16       Impact factor: 4.562

9.  Farnesylation of Ydj1 is required for in vivo interaction with Hsp90 client proteins.

Authors:  Gary A Flom; Marta Lemieszek; Elizabeth A Fortunato; Jill L Johnson
Journal:  Mol Biol Cell       Date:  2008-10-01       Impact factor: 4.138

10.  Hsp40 chaperones promote degradation of the HERG potassium channel.

Authors:  Valerie E Walker; Michael J H Wong; Roxana Atanasiu; Christine Hantouche; Jason C Young; Alvin Shrier
Journal:  J Biol Chem       Date:  2009-11-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.